Cilostazol for Preventing Recurrent Stroke

Cilostazol for Prevention of Recurrent Stroke Trial

Recruiting Phase 3 Interventional Study
Stroke Recurrence Myocardial Infarction Vascular Death Ischemic Stroke TIA (Transient Ischemic Attack) Stroke (CVA) or Transient Ischemic Attack Recurrent Stroke
Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
2,000 (estimated)
Sponsor
Stanford University · Other
Who this trial is looking for

This trial is looking for people who have had a stroke or mini-stroke within the last 6 months. Participants will take a medication called cilostazol or a placebo and be monitored for up to 5 years to see if it helps prevent further strokes or heart attacks.

Are You a Good Fit for This Trial?
Must be taking AspirinClopidogrelTicagrelor

You may be able to join if

  • I am 40 years old or older.
  • I have had an ischemic stroke or a high-risk mini-stroke.
  • I can start this trial within 180 days after my stroke or mini-stroke.
  • I am taking medication as advised by my healthcare provider.
  • I have two or more risk factors for strokes, like being older or having high blood pressure.
  • I am medically stable and can attend follow-up appointments.
  • I can receive the study drug by mail.
  • I have signed the informed consent form.

You may not be able to join if

  • I have atrial fibrillation or a mechanical heart valve.
  • I have had a serious brain bleed in the last 2 years.
  • I am pregnant, breastfeeding, or not using birth control.
  • I have severe liver problems.
  • I am enrolled in another clinical study.
  • I have heart failure with current symptoms.
  • I expect to live less than 6 months.
  • I do not allow my healthcare provider to share health information if needed.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this clinical study is to learn if adding a medicine called cilostazol to usual treatment can help prevent another stroke, a heart attack, or death in patients who had a stroke caused by a blocked blood vessel, or a "mini-stroke" (also called a TIA), in the past 6 months. To determine if cilostazol is safe and effective at lowering the chance of strokes, heart attacks and deaths, the …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. ≥40 years 2. Ischemic stroke or high-risk TIA (ABCD2 score ≥6) 3. Can be randomized within 180 days after ischemic stroke or high-risk TIA 4. Treatment with single or dual antithrombotic therapy with aspirin, clopidogrel and/or ticagrelor per international and/or national gui…
Contacts

No contact information available.